Company
AvidiaMed GmbH is a pharmaceutical company spezialising in innovative medication solutions. AvidiaMed is manufacturing authorisation holder according to §13 German Pharmaceutical Act and since April 2010 with several regional initiatives active in the German market.
The MediFalter - the safest and most personal form of drug therapy for the German market
The different tablets prescribed for the chronically ill by their doctor are individually and clearly pre-sorted for one week (seven days) and combined in a pack. The MediFalter simplifies daily use of medication, makes taking medication safer and makes patients everyday lives easier - with the goal of increasing adherence to therapy.
AvidiaMed GmbH
Nagelsweg 33-35
20097 Hamburg
Germany
T +49 40 21107-380
F +49 40 21107-381
12.04.2011 Healthnet East Hesse and AvidiaMed start together initiative to increase medication regiment safety
According to estimates by the WHO, the World Health Organisation,
only about half
of all chronically ill
patients comply with their doctor's
precise recommendations for taking their medication.
According to studies,
more than six million patients in Germany take more than three drugs daily.
The direct and indirect costs of non-compliance in Germany are estimated at between
7.5 and 10 billion euros per year.
Compliance rate: for one tablet per day 80 per cent, for four tablets to be taken per day only 30 percent.
